Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $0.71 in the prior trading day, Nautilus Biotechnology Inc (NASDAQ: NAUT) closed at $0.73, up 2.11%. In other words, the price has increased by $2.11 from its previous closing price. On the day, 0.57 million shares were traded. NAUT stock price reached its highest trading level at $0.7315 during the session, while it also had its lowest trading level at $0.6901.
Ratios:
Our goal is to gain a better understanding of NAUT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.52 and its Current Ratio is at 18.52. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’25 when Patel Sujal M bought 116,500 shares for $0.67 per share. The transaction valued at 78,544 led to the insider holds 10,258,221 shares of the business.
Patel Sujal M bought 83,500 shares of NAUT for $57,031 on Sep 08 ’25. The CEO, President, and Secretary now owns 10,341,721 shares after completing the transaction at $0.68 per share. On Sep 04 ’25, another insider, Murphy Matthew B., who serves as the General Counsel of the company, bought 20,000 shares for $0.64 each. As a result, the insider paid 12,858 and bolstered with 74,140 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAUT now has a Market Capitalization of 91609104 and an Enterprise Value of -28080896.
Stock Price History:
The Beta on a monthly basis for NAUT is 1.29, which has changed by -0.74290776 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, NAUT has reached a high of $3.09, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is 0.84%, while the 200-Day Moving Average is calculated to be -32.54%.
Shares Statistics:
The stock has traded on average 341.19K shares per day over the past 3-months and 436800 shares per day over the last 10 days, according to various share statistics. A total of 126.31M shares are outstanding, with a floating share count of 59.68M. Insiders hold about 52.75% of the company’s shares, while institutions hold 27.27% stake in the company. Shares short for NAUT as of 1756425600 were 225333 with a Short Ratio of 0.66, compared to 1753920000 on 268176. Therefore, it implies a Short% of Shares Outstanding of 225333 and a Short% of Float of 0.45999999999999996.
Earnings Estimates
The market rating of Nautilus Biotechnology Inc (NAUT) is currently shaped by the ongoing analysis conducted by 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.14 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.53 and -$0.61 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.66, with 2.0 analysts recommending between -$0.59 and -$0.73.
